Shares of Linde PLC (NYSE:LIN) have been given an average rating of “Buy” by the nineteen research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and twelve have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $200.35.
A number of research analysts have commented on the company. KeyCorp downgraded Steris from an “overweight” rating to a “sector weight” rating in a research note on Tuesday, July 9th. They noted that the move was a valuation call. UBS Group restated a “buy” rating on shares of Linde in a research note on Friday, July 12th. ValuEngine upgraded Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Monday, April 1st. DZ Bank upgraded Linde to a “buy” rating in a research note on Friday, May 17th. Finally, Barclays set a $192.00 target price on Tesla and gave the company a “sell” rating in a research note on Tuesday, May 14th.
In other news, CEO Stephen F. Angel sold 56,574 shares of the company’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $197.27, for a total transaction of $11,160,352.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Christian Bruch purchased 1,474 shares of the firm’s stock in a transaction dated Wednesday, May 15th. The shares were bought at an average price of $179.21 per share, with a total value of $264,155.54. The disclosure for this purchase can be found here. Corporate insiders own 0.70% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in LIN. Comerica Securities Inc. bought a new stake in shares of Linde during the 4th quarter worth about $309,000. First Trust Advisors LP acquired a new position in shares of Linde during the 4th quarter worth about $416,000. GSA Capital Partners LLP acquired a new position in shares of Linde during the 4th quarter worth about $318,000. Great West Life Assurance Co. Can acquired a new position in shares of Linde during the 4th quarter worth about $860,000. Finally, Bessemer Group Inc. acquired a new position in shares of Linde during the 4th quarter worth about $120,000. Institutional investors own 72.83% of the company’s stock.
Shares of LIN stock traded down $0.26 on Friday, reaching $203.38. 1,228,262 shares of the company’s stock traded hands, compared to its average volume of 1,529,546. Linde has a 12-month low of $145.95 and a 12-month high of $205.55. The company has a quick ratio of 1.20, a current ratio of 1.35 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $110.82 billion, a P/E ratio of 31.83, a P/E/G ratio of 2.19 and a beta of 0.77. The company has a 50 day moving average of $199.91.
Linde (NYSE:LIN) last issued its quarterly earnings results on Friday, May 10th. The basic materials company reported $1.69 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.15. Linde had a return on equity of 14.95% and a net margin of 23.52%. The business had revenue of $6.94 billion for the quarter, compared to the consensus estimate of $7.03 billion. On average, equities research analysts expect that Linde will post 6.95 EPS for the current year.
Linde Company Profile
Linde plc operates as an industrial gas company in primarily North and South America, Europe, the Middle East, Africa, the Asia Pacific, and South Korea. The company offers oxygen, nitrogen, argon, rare gases, carbon monoxide, carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Featured Story: Catch-Up Contributions
Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.